Aligned Genetics, Inc. (KOSDAQ:238120)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Life Science Research and Diagnostics			15.21B	13.75B	11.76B	7.96B	7.79B
Life Science Research and Diagnostics Growth			10.63%	16.92%	47.82%	2.10%	37.33%
Total			15.21B	13.75B	11.76B	7.96B	7.79B
Total Growth			10.63%	16.92%	47.82%	2.10%	37.33%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
South Korea			1.87B	2.32B	2.64B	1.06B	1.16B
South Korea Growth			-19.61%	-12.06%	149.32%	-8.87%	35.94%
United States of America (USA)			4.82B	3.76B	3.08B	2.27B	2.29B
United States of America (USA) Growth			28.36%	22.02%	35.69%	-0.91%	28.14%
France			1.87B	1.09B	676.17M	609.93M	346.52M
France Growth			72.07%	60.67%	10.86%	76.02%	-
Japan			944.57M	755.66M	979.71M	713.38M	695.82M
Japan Growth			25.00%	-22.87%	37.33%	2.52%	32.64%
Europe			3.57B	4.30B	2.96B	2.08B	1.96B
Europe Growth			-16.98%	45.19%	42.57%	5.64%	25.77%
Others			2.15B	1.54B	1.43B	1.23B	1.34B
Others Growth			39.76%	7.58%	15.97%	-7.81%	40.99%
Total			15.21B	13.75B	11.76B	7.96B	7.79B
Total Growth			10.63%	16.92%	47.82%	2.10%	37.33%

Source: S&P Global Market Intelligence.